PERKINS PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: P85608 | OLDHAM, OL1 1NL
Showing results 151-200 of 407
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Betamethasone valerate | 99 | 7,790 | £926 | -74.3% ▼ |
| 99 | 198 | £7.0K | -81.8% ▼ | |
| Docusate sodium | 98 | 12.1K | £826 | -73.6% ▼ |
| Carbomer 940/980 | 98 | 1,630 | £442 | -35.6% ▼ |
| Formoterol/glycopyrronium/budesonide | 97 | 97 | £4.1K | +61.1% ▲ |
| Powder extensively hydrolysed formula (0913101) | 96 | 169.6K | £4.9K | +33.3% ▲ |
| Digoxin | 95 | 1,820 | £134 | -74.9% ▼ |
| Insulin aspart | 95 | 474 | £3.2K | -75.1% ▼ |
| Aripiprazole | 93 | 1,862 | £301 | -63.5% ▼ |
| Ropinirole hydrochloride | 93 | 4,048 | £2.2K | -12.5% ▼ |
| Lymecycline | 93 | 2,555 | £297 | -22.7% ▼ |
| Quinine bisulfate | 93 | 2,492 | £447 | +139.5% ▲ |
| Fentanyl | 91 | 910 | £4.6K | -11.2% ▼ |
| Letrozole | 89 | 3,276 | £308 | -52.3% ▼ |
| Methylphenidate hydrochloride | 87 | 2,786 | £2.4K | -66.3% ▼ |
| Nicotine | 86 | 2,167 | £2.1K | +52.3% ▲ |
| Pantoprazole | 85 | 1,848 | £92 | -69.1% ▼ |
| Moxonidine | 85 | 3,836 | £521 | +52.7% ▲ |
| Promazine hydrochloride | 83 | 3,349 | £2.0K | +57.2% ▲ |
| Pizotifen malate | 83 | 6,804 | £292 | +0.7% vs avg |
| Loratadine | 81 | 1,974 | £47 | -61.2% ▼ |
| Calcipotriol | 80 | 9,900 | £6.1K | -53.0% ▼ |
| Other toiletry preparations | 79 | 29.8K | £519 | +85.0% ▲ |
| 79 | 13.6K | £647 | -22.2% ▼ | |
| Norethisterone | 78 | 8,286 | £1.4K | +60.8% ▲ |
| Clobazam | 77 | 2,732 | £310 | +16.8% ▲ |
| Methotrexate | 77 | 2,464 | £146 | -76.3% ▼ |
| Insulin glargine | 76 | 405 | £3.0K | -73.2% ▼ |
| Semaglutide | 74 | 1,529 | £6.0K | -69.3% ▼ |
| 74 | 649 | £237 | -27.6% ▼ | |
| Etoricoxib | 73 | 1,099 | £271 | -9.4% ▼ |
| Carbimazole | 69 | 2,786 | £109 | -38.9% ▼ |
| Carvedilol | 68 | 3,122 | £97 | -40.1% ▼ |
| Zinc oxide | 67 | 1,686 | £229 | +223.8% ▲ |
| Estradiol with progestogen | 67 | 3,472 | £1.4K | -80.3% ▼ |
| 67 | 6,629 | £467 | -69.0% ▼ | |
| Baclofen | 65 | 15.1K | £174 | -67.6% ▼ |
| Phenobarbital | 63 | 4,424 | £697 | +104.9% ▲ |
| Perindopril erbumine | 62 | 1,836 | £105 | -88.3% ▼ |
| Olanzapine | 62 | 2,100 | £209 | -83.3% ▼ |
| Orlistat | 62 | 5,208 | £1.2K | -24.8% ▼ |
| Aciclovir | 61 | 3,042 | £117 | -59.0% ▼ |
| Temazepam | 60 | 2,011 | £1.8K | +4.9% ▲ |
| 59 | 59 | £98 | -73.2% ▼ | |
| Fluconazole | 58 | 570 | £128 | -25.0% ▼ |
| Permethrin | 58 | 4,350 | £1.2K | +53.9% ▲ |
| 58 | 5,350 | £248 | +6.9% ▲ | |
| 57 | 6,630 | £219 | -79.4% ▼ | |
| Fusidic acid | 56 | 2,220 | £259 | -56.1% ▼ |
| Biphasic insulin aspart | 55 | 505 | £3.0K | -45.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.